Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7367 p328
17 September 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacists trained to give flu vaccines

Pharmacists working within City and Hackney Primary Care Trust were trained to administer influenza vaccines last week in an attempt to improve uptake of the vaccine in east London during this year's annual flu campaign.

Jonathan Mason, head of prescribing and pharmacy at City and Hackney PCT told The Journal that last year the PCT achieved only a 59 per cent uptake of flu vaccination among its 20,000 target patients — the worst result in the UK. “This year we are pulling out all the stops,” said Mr Mason, who is also flu co-ordinator for the PCT.“It was clear to us that we needed to do something different to get these patients immunised and pharmacists are ideally placed,” he added.

The PCT is using two approaches to capture patients. Accredited community pharmacists will identify at-risk patients who bring in prescriptions for dispensing and check if they have received the vaccine. If they have not received it, pharmacists will offer to administer the vaccine in a private consultation area in their pharmacy.

In addition, the PCT is commissioning pharmacists to run clinics in practices that have been particularly poor performers.

A service level agreement for this enhanced service is in place, and pharmacists will receive a retainer fee to cover the campaign, training, records and audit, plus £7.51 for each vaccine administered. As part of the agreement, records of who has been vaccinated must be given to the GP practice on the day of vaccination where feasible.

A total of 54 pharmacists undertook the one-day training course, which was run by a nursing teacher from City University London. It included recognition of anaphylaxis, the principles of immunisation and practical vaccination skills.

Mr Mason hopes that, if the initiative is a success, pharmacists will be used for other vaccination campaigns, including childhood immunisations, in the future.

Back to Top


©The Pharmaceutical Journal